Muscle Strength and Aerobic Capacity in HIV-Infected Patients: A Systematic Review and Meta-Analysis

被引:23
作者
Gomes-Neto, Mansueto [1 ,2 ]
Rodriguez, Indira [1 ]
Ledo, Ana P. [1 ]
Vieira, Joao P. B. [2 ]
Brites, Carlos [1 ]
机构
[1] Univ Fed Bahia UFBA, Programa Posgrad Med & Saude, Salvador, BA, Brazil
[2] Univ Fed Bahia UFBA, Curso Fisioterapia, Dept Fisioterapia, Salvador, BA, Brazil
关键词
HIV; muscle strength; physical activity; meta-analysis; HUMAN-IMMUNODEFICIENCY-VIRUS; QUALITY-OF-LIFE; FUNCTIONAL IMPAIRMENT; EXERCISE CAPACITY; PHYSICAL FUNCTION; GRIP STRENGTH; YOUNG-ADULTS; CHILDREN; INDIVIDUALS; FITNESS;
D O I
10.1097/QAI.0000000000001835
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Physical impairment is highly prevalent in HIV-infected patients. We conducted a systematic review of published studies that included studies comparing muscle function in HIV-infected patients to matched healthy controls, and studies comparing aerobic capacity in HIV-infected patients with that observed in matched healthy controls. Design: Systematic review and meta-analysis. Methods: We searched for references on MEDLINE, SciELO, Cumulative Index to Nursing and Allied Health (CINAHL), and Scopus up to December 2017. Weighted mean differences and 95% confidence intervals (CIs) were calculated, and heterogeneity was assessed using the I-2 test. Results: A total of 30 studies, covering 2148 healthy controls and 2161 HIV-infected patients, fulfilled the inclusion criteria. The average muscle strength and aerobic capacity were significantly lower in HIV-infected patients. Meta-analysis revealed moderate-quality evidence of weaker muscle strength and aerobic capacity in HIV-infected patients. A significant difference in lower-body strength of 1.07 (95% CI: 0.29 to 1.84) was found for participants in the healthy control group compared with HIV group. A significant difference in aerobic capacity (peak VO2) of 8.4 (95% CI: 4.8 to 12.0) was found for participants in the healthy control group compared with HIV group. Conclusions: Muscle strength and aerobic capacity of HIV-infected patients are reduced in comparison with healthy controls. Additional studies are needed to define the best interventions to improve the physical function in HIVinfected patients.
引用
收藏
页码:491 / 500
页数:10
相关论文
共 58 条
[21]   Exercise intolerance in adult congenital heart disease - Comparative severity, correlates, and prognostic implication [J].
Diller, GP ;
Dimopoulos, K ;
Okonko, D ;
Li, W ;
Babu-Narayan, SV ;
Broberg, CS ;
Johansson, B ;
Bouzas, B ;
Mullen, MJ ;
Poole-Wilson, PA ;
Francis, DP ;
Gatzoulis, MA .
CIRCULATION, 2005, 112 (06) :828-835
[22]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[23]   Functional Impairment, Disability, and Frailty in Adults Aging with HIV-Infection [J].
Erlandson, Kristine M. ;
Schrack, Jennifer A. ;
Jankowski, Catherine M. ;
Brown, Todd T. ;
Campbell, Thomas B. .
CURRENT HIV/AIDS REPORTS, 2014, 11 (03) :279-290
[24]   Functional Impairment Is Associated With Low Bone and Muscle Mass Among Persons Aging With HIV Infection [J].
Erlandson, Kristine M. ;
Allshouse, Amanda A. ;
Jankowski, Catherine M. ;
MaWhinney, Samantha ;
Kohrt, Wendy M. ;
Campbell, Thomas B. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (02) :209-215
[25]   Prognostic impact of peakVO2-changes in stable CHF on chronic beta-blocker treatment. [J].
Frankenstein, L. ;
Nelles, M. ;
Hallerbach, M. ;
Dukic, D. ;
Fluegel, A. ;
Schellberg, D. ;
Katus, H. A. ;
Remppis, A. ;
Zugck, C. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 (02) :125-130
[26]  
Githinji LN, 2017, ANN AM THORAC SOC, V14, P722, DOI [10.1513/AnnalsATS.201612-1018OC, 10.1513/annalsats.201612-1018oc]
[27]   Effects of Combined Aerobic and Resistance Exercise on Exercise Capacity, Muscle Strength and Quality of Life in HIV-Infected Patients: A Systematic Review and Meta-Analysis [J].
Gomes Neto, Mansueto ;
Conceicao, Cristiano Sena ;
Carvalhom, Vitor Oliveira ;
Brites, Carlos .
PLOS ONE, 2015, 10 (09)
[28]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION AND MYOPATHY - CLINICAL RELEVANCE OF ZIDOVUDINE THERAPY [J].
GRAU, JM ;
MASANES, F ;
PEDROL, E ;
CASADEMONT, J ;
FERNANDEZSOLA, J ;
URBANOMARQUEZ, A .
ANNALS OF NEUROLOGY, 1993, 34 (02) :206-211
[29]   Neuromuscular response of young boys versus men during sustained maximal contraction [J].
Halin, R ;
Germain, P ;
Bercier, S ;
Kapitaniak, B ;
Buttelli, O .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2003, 35 (06) :1042-1048
[30]  
Higgins J., 2006, Cochrane handbook for systematic reviews of interventions 4.2.6, V4